Abstract
Background Structural brain lesions are the most common cause of adult-onset epilepsy. The lesion location may contribute to the risk for epileptogenesis, but whether specific lesion locations are associated with a risk for secondary seizure generalization from focal to bilateral tonic-clonic seizures, is unknown.
Methods We identified patients with a diagnosis of adult-onset epilepsy caused by an ischemic stroke or a tumor diagnosed at the Turku University Hospital in 2004-2017. Lesion locations were segmented on patient-specific MR imaging and transformed to a common brain atlas (MNI space). Both region-of-interest analyses (intersection with the cortex, hemisphere, and lobes) and voxel-wise analyses were conducted to identify the lesion locations associated with focal to bilateral tonic-clonic compared to focal seizures.
Results We included 170 patients with lesion-induced epilepsy (94 tumors, 76 strokes). Lesions predominantly localized in the cerebral cortex (OR 2.50, 95% C.I. 1.21-5.15, p = 0.01) and right hemisphere (OR 2.22, 95% C.I. 1.17-4.20, p = 0.01) were independently associated with focal to bilateral tonic-clonic seizures. At the lobar-level, focal to bilateral tonic-clonic seizures were associated with lesions in the right frontal cortex (OR 4.41, 95% C.I. 1.44-13.5, p = 0.009). No single voxels were significantly associated with seizure type. These effects were independent of lesion etiology.
Conclusions Our results demonstrate that lesion location is associated with the risk for secondary generalization of epileptic seizures independent of lesion etiology. These findings may contribute to identifying patients at risk for focal to bilateral tonic-clonic seizures.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
JN, MB and LN have nothing to report. JJ has received research funding from the Finnish Foundation for Alcohol Studies, Finnish Medical Foundation, Finnish Parkinson Foundation, University of Turku and Turku University Hospital (VTR funding), and lecturer honorarium from Lundbeck.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol was approved by Turku University Hospital Clinical Research Services Board, and the study was conducted according to the principles of the Declaration of Helsinki. Due to the retrospective register-based nature of the clinical data collection and large sample size, the need for separate ethical board review and obtaining written consent from the patients was waived.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Supplemental files updated. Tables updated.
Data Availability
Voxelwise maps are available upon reasonable request. The original data cannot be made publicly available.